“● yeotop3.com ● 소사동오피Ⅰ소사동립카페♅소사동풀싸롱☰소사동마사지∮소사동오피❃소사동출장こ소사동OP”的搜索结果，显示 231-240 项，共有 6368 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6- ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression ...

8. 乳腺癌- 医生与科室- 妙佑医疗国际

   了解这种常见的癌症，包括有关预防、症状、诊断和治疗的信息。

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate invasive disease-free survival (iDFS) of multi-epitope HER2 vaccine vs. placebo in combination with ado-trastuzumab ...

10. 乳腺癌- 医生与科室- 妙佑医疗国际

    了解这种常见的癌症，包括有关预防、症状、诊断和治疗的信息。